|
Volumn 11, Issue 18, 2001, Pages 2449-2452
|
Identification of E2F-1/Cyclin A antagonists
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLLYSYLARGINYLLYSYLLEUCYLPHENYLALANYLGLYCINE;
ANTINEOPLASTIC AGENT;
CYCLIN A;
CYCLIN DEPENDENT KINASE INHIBITOR;
LACTAM DERIVATIVE;
OCTAPEPTIDE;
PROLYLALANYLLYSYLARGINYLLYSYLPHENYLALANYLGLYCINE;
PROLYLLEUCYLSPIROLACTAM;
PROLYLVALYLLYSYLARGINYLARGINYLLEUCYLASPARTYLLEUCINE;
TRANSCRIPTION FACTOR E2F;
UNCLASSIFIED DRUG;
ARTICLE;
BINDING AFFINITY;
BINDING SITE;
CHEMICAL REACTION;
DRUG ACTIVITY;
DRUG POTENCY;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME INHIBITION;
IC 50;
PROTEIN MOTIF;
PROTEIN PROTEIN INTERACTION;
REACTION ANALYSIS;
AMINO ACID SEQUENCE;
BINDING SITES;
BIOCHEMISTRY;
CELL CYCLE PROTEINS;
COMBINATORIAL CHEMISTRY TECHNIQUES;
CONSERVED SEQUENCE;
CYCLIN A;
DNA-BINDING PROTEINS;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
E2F TRANSCRIPTION FACTORS;
E2F1 TRANSCRIPTION FACTOR;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
INHIBITORY CONCENTRATION 50;
PEPTIDE LIBRARY;
PEPTIDES;
STRUCTURE-ACTIVITY RELATIONSHIP;
TRANSCRIPTION FACTORS;
|
EID: 0035903893
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(01)00486-3 Document Type: Article |
Times cited : (16)
|
References (14)
|